Results 51 to 60 of about 774,384 (405)

Fibrotic Idiopathic Interstitial Lung Disease: The Molecular and Cellular Key Players

International Journal of Molecular Sciences, 2021
Interstitial lung diseases (ILDs) that are known as diffuse parenchymal lung diseases (DPLDs) lead to the damage of alveolar epithelium and lung parenchyma, culminating in inflammation and widespread fibrosis.
A. V. Samarelli, R. Tonelli, A. Marchioni, G. Bruzzi, F. Gozzi, D. Andrisani, I. Castaniere, L. Manicardi, A. Moretti, L. Tabbì, S. Cerri, B. Beghé, M. Dominici, E. Clini   +13 more
semanticscholar   +1 more source

Lung ultrasound in systemic sclerosis: correlation with high-resolution computed tomography, pulmonary function tests and clinical variables of disease [PDF]

, 2015
Interstitial lung disease (ILD) is a hallmark of systemic sclerosis (SSc). Although high-resolution computed tomography (HRCT) is the gold standard to diagnose ILD, recently lung ultrasound (LUS) has emerged in SSc patients as a new promising technique ...
Amoroso, Antonio, Barbano, Biagio, Barilaro, Giuseppe, Gigante, Antonietta, Giovannetti, Antonello, Lucci, Silvio, Quarta, Silvia, Rosato, Edoardo, ROSSI FANELLI, Filippo   +8 more
core   +1 more source

Overnight desaturation in interstitial lung diseases: links to pulmonary vasculopathy and mortality

ERJ Open Research
Background Overnight desaturation predicts poor prognosis across interstitial lung diseases (ILDs). The aim of the present study was to investigate whether nocturnal desaturation is associated with pulmonary vasculopathy and mortality.
George A. Margaritopoulos, Athanasia Proklou, Athina Trachalaki, Diana Badenes Bonet, Maria Kokosi, Vasilis Kouranos, Felix Chua, Peter George, Elisabetta A. Renzoni, Anand Devaraj, Sujal Desai, Andrew G. Nicholson, Katerina M. Antoniou, Athol U. Wells   +13 more
doaj   +1 more source

Patient perspectives on home-spirometry in interstitial lung disease: a qualitative co-designed study

BMJ Open Respiratory Research, 2023
Background Opportunities for home-monitoring are increasing exponentially. Home- spirometry is reproducible and reliable in interstitial lung disease (ILD), yet patients’ experiences are not reported.
Sarah Lines, Michael Gibbons, Rebecca Shuttleworth, Anne-Marie Russell, Graham Brown, Anna Duckworth, Alex Berry, Jessica Mandizha, Joseph W Lanario, Ana Paiva, Victoria Elworthy, Veena Muraleedharan, Ana Jorge Da Ponte, Howard Almond, Carole Bond, Maureen Cosby, Joanne Dallas, Marium Naqvi, Adam David Russell, Christopher J Scotton   +19 more
doaj   +1 more source

Prognostic value of serum oncomarkers for patients hospitalized with acute exacerbation of interstitial lung disease

Therapeutic Advances in Respiratory Disease
Background: Different types of inflammatory processes and fibrosis have been implicated in the pathogenesis of interstitial lung disease (ILD), a heterogeneous, diffuse, parenchymal lung disease.
Cuirong Ba, Chunguo Jiang, Huijuan Wang, Xuhua Shi, Jiawei Jin, Qiuhong Fang   +5 more
semanticscholar   +1 more source

Progressive fibrosing interstitial lung disease: a clinical cohort (the PROGRESS study)

European Respiratory Journal, 2020
In patients with chronic fibrosing interstitial lung disease (ILD), a progressive fibrosing phenotype (PF-ILD) may develop, but information on the frequency and characteristics of this population outside clinical trials is lacking.
M. Nasser, S. Larrieu, S. Si-Mohamed, K. Ahmad, L. Boussel, M. Brevet, L. Chalabreysse, C. Fabre, S. Marque, D. Revel, F. Thivolet-Béjui, J. Traclet, S. Zeghmar, D. Maucort-Boulch, V. Cottin   +14 more
semanticscholar   +1 more source

Assessment of pulmonary edema: principles and practice [PDF]

, 2018
Pulmonary edema increasingly is recognized as a perioperative complication affecting outcome. Several risk factors have been identified, including those of cardiogenic origin, such as heart failure or excessive fluid administration, and those related to ...
Assaad, Sherif, Friedman, Malcolm B., Kratzert, Wolf B., Perrino, Albert, Shelley, Benjamin   +4 more
core   +1 more source

Systematic review of drug effects in humans and models with surfactant-processing disease

European Respiratory Review, 2018
Fibrotic interstitial pneumonias are a group of rare diseases characterised by distortion of lung interstitium. Patients with mutations in surfactant-processing genes, such as surfactant protein C (SFTPC), surfactant protein A1 and A2 (SFTPA1 and A2 ...
Dymph Klay, Thijs W. Hoffman, Ankie M. Harmsze, Jan C. Grutters, Coline H.M. van Moorsel   +4 more
doaj   +1 more source

Smoking-related interstitial lung disease [PDF]

, 2011
Cigarette smoking has a clear epidemiological association with lung diseases, characterised by chronic inflammation of both the bronchiolar and the interstitial lung compartments.
CERRI, Stefania, F. Luppi, RICHELDI, Luca, SPAGNOLO, Paolo   +3 more
core   +1 more source

Recent advances in the treatment of systemic sclerosis associated interstitial lung disease

Frontiers in Medicine, 2023
Connective tissue diseases (CTDs) are a heterogenous group of systemic inflammatory disorders. The development of connective tissue disease-associated interstitial lung disease (CTD-ILD) is a key complication associated with significant morbidity and ...
Antoniya Kamenova, Argyris Tzouvelekis, George A. Margaritopoulos   +2 more
doaj   +1 more source